Skip to main content

Table 3 Characteristics of the patients (N = 4,946)

From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

 

Patients (n = 4,946)

Age (mean, standard deviation)

43.9 (15.7)

> = 55 years (%)

25.4

Sex ratio (male:female)

1.3

WHO regions (%)

 

 Africa

52.9

 America

0.7

 Eastern Europe

33.8

 Pacifica

1.6

 South East Asia

11.0

Diagnostic: CML (%)

91.4

Initial Phase (%)

 

 Chronic

84.7

 Accelerated

13.3

 Blast crisis

2.0

Status (%)

 

 Active

70.5

 Closed

27.5

 Denied

2.0

Duration of follow up (month; mean, standard deviation)

25.8 (25.9)